Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
Dennis Bourdette1, Lindsey Wooliscroft2
1Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.
Abstract
No abstract available in PubMed .
More Related Videos
07:41A Neurite Outgrowth Assay and Neurotoxicity Assessment with Human Neural Progenitor Cell-Derived Neurons
Published on: August 6, 2020
7.5K
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12.2K
